US health agencies sound warning on J&J talc bankruptcy
Two U.S. federal health agencies have objected to Johnson & Johnson's $10 billion proposed settlement of tens of thousands of ...
J&J Talc Deal Should Be Rejected in Bankruptcy, Holdouts Say
Holdout creditors who claim tainted baby powder gave them ovarian cancer urged a judge to reject Johnson & Johnson’s plan to ...
Crain's Chicago Business10h
With DEI under attack, Kellogg assembling institute to address racial wealth gap
The $25 million effort will be named for Jim Lowry, a consultant and Kellogg icon who was McKinsey's first Black hire.
Bears' Ben Johnson tabs NFL's youngest coordinator, also hires ex-head coach for new staff, per report
The Chicago Bears recently got their new head coach in Ben Johnson. Now they have two right-hand men for Johnson, on Sunday hiring former New Orleans Saints coach Dennis Allen as the team's new ...
Ex-J&J Executive Fails to Advance Prescription Drug Cost Suit
A former Johnson & Johnson executive’s allegations that the drug company overpaid for prescription drug benefits are ...
JNJ ALERT: Levi & Korsinsky Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Johnson & Johnson
Levi & Korsinsky notifies investors that it has commenced an investigation of Johnson & Johnson ('Johnson & Johnson') (NYSE:JNJ) concerning ...
FDA approves Johnson & Johnson’s nasal spray for depression as stand-alone treatment
Spravato is now the first-ever stand-alone therapy for treatment-resistant depression, and is on its way to becoming a ...
USA Today6d
House Speaker Mike Johnson's victory came with a warning from hardline Republicans
WASHINGTON – House Republicans gave Mike Johnson the speaker's gavel on Friday – along with a warning. Nine GOP lawmakers at first either abstained from voting for Johnson or voted for a ...
S&P Places Johnson & Johnson on CreditWatch Negative
S&P Global Ratings placed Johnson & Johnson on CreditWatch with negative implications, citing its nearly $15 billion deal to acquire mental-illness drug developer Intra-Cellular Therapies.
Johnson & Johnson to Acquire Intra-Cellular in $15 Billion Deal
Pharmaceutical giants have recently shown new enthusiasm for mental-health treatments with vast but unrealized promise.
KIRO-TV14d
J&J buys Intra-Cellular in $14.6 billion deal, delving further into central nervous system disorders
Johnson & Johnson will spend more than $14 billion to delve further into the treatment of central nervous system disorders by purchasing Intra-Cellular Therapies. The health care giant said Monday ...
What Johnson & Johnson Is Getting With The Acquisition Of Intra-Cellular Therapies
Johnson & Johnson acquires Intra-Cellular Therapies for $14.6 billion. The biggest driver was the rights Caplyta which has blockbuster potential. Learn more on ITCI stock here.